Increasing treatment accuracy for cervical cancer patients using correlations between bladder-filling change and cervix-uterus displacements: Proof of principle

被引:59
作者
Ahmad, Rozilawati [1 ,2 ]
Hoogeman, Mischa S. [2 ]
Bondar, Maria [2 ]
Dhawtal, V. [2 ]
Quint, Sandra [2 ]
De Pree, Ilse [2 ]
Mens, Jan Willem [2 ]
Heijmen, Ben J. M. [2 ]
机构
[1] Univ Kebangsaan Malaysia, Fac Allied Hlth Sci, Diagnost Imaging & Radiotherapy Programme, Kuala Lumpur 50300, Malaysia
[2] Erasmus MC Daniel Hoed Canc Ctr, Dept Radiat Oncol, Rotterdam, Netherlands
关键词
Bladder volume; Cervix cancer; Internal-organ motion; Radiotherapy; Adaptive RI; WEEKLY CT EVALUATION; INTERFRACTIONAL VARIATION; GYNECOLOGICAL CANCER; DOSE DISTRIBUTION; RADIOTHERAPY; MOTION; MOVEMENT; POSITION; UTERINE; VOLUME;
D O I
10.1016/j.radonc.2010.11.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate application of pre-treatment established correlations between bladder-filling changes and cervix-uterus displacements in adaptive therapy. Materials and methods: Thirteen cervical cancer patients participated in this prospective study. Pre-treatment, and after delivery of 40 Gy, a full bladder CT-scan was acquired, followed by voiding the bladder and acquisition of 4 other 3D scans in a 1 h period with a naturally filling bladder (variable bladder filling CT-scans, VBF-scans). For the pre-treatment VBF-scans, linear correlations between bladder volume change and displacements of the tip of the uterus (IOU) and the center of mass (CoM) of markers implanted in the fornices of the vagina relative to the full bladder planning scan were established. Prediction accuracy of these correlation models was assessed by comparison with actual displacements in CT-scans, both pre-treatment and after 40 Gy. Inter-fraction ToU and marker-CoM displacements were derived from the established correlations and twice-weekly performed in-room bladder volume measurements, using a 3D ultrasound scanner. Results: Target displacement in VHF-scans ranged from up to 65 mm in a single direction to almost 0 mm, depending on the patient. For pre-treatment VBF-scans, the linear correlation models predicted the mean 3D position change for the ToU of 26.1 mm +/- 10.8 with a residual of only 2.2 mm +/- 1.7. For the marker-CoM, the 8.4 mm +/- 5.3 mean positioning error was predicted with a residual of 0.9 mm +/- 0.7. After 40 Gy, the mean ToU displacement was 26.8 mm +/- 15.8, while prediction based on the pre-treatment correlation models yielded a mean residual error of 9.0 mm +/- 3.7. Target positioning errors in the fractioned treatments were very large, especially for the ToU (-18.5 mm +/- 11.2 for systematic errors in SI-direction). Conclusions: Pre-treatment acquired VBF-scans may be used to substantially enhance treatment precision of cervical cancer patients. Application in adaptive therapy is promising and warrants further investigation. For highly conformal (IMRT) treatments, the use of a full bladder drinking protocol results in unacceptably large systematic set-up errors. (C) 2011 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 98 (2011) 340-346
引用
收藏
页码:340 / 346
页数:7
相关论文
共 13 条
  • [1] Inter-fraction bladder filling variations and time trends for cervical cancer patients assessed with a portable 3-dimensional ultrasound bladder scanner
    Ahmad, Rozilawati
    Hoogeman, Mischa S.
    Quint, Sandra
    Mens, Jan Willem
    de Pree, Ilse
    Heijmen, Ben J. M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 89 (02) : 172 - 179
  • [2] A symmetric nonrigid registration method to handle large organ deformations in cervical cancer patients
    Bondar, Luiza
    Hoogeman, Mischa S.
    Osorio, Eliana M. Vasquez
    Heijmen, Ben J. M.
    [J]. MEDICAL PHYSICS, 2010, 37 (07) : 3760 - 3772
  • [3] Impact of the filling status of the bladder and rectum on their integral dose distribution and the movement of the uterus in the treatment planning of gynaecological cancer
    Buchali, A
    Koswig, S
    Dinges, S
    Rosenthal, P
    Salk, J
    Lackner, G
    Böhmer, D
    Schlenger, L
    Budach, V
    [J]. RADIOTHERAPY AND ONCOLOGY, 1999, 52 (01) : 29 - 34
  • [4] Inter- and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: A cinematic-MRI point-of-interest study
    Chan, Philip
    Dinniwell, Robert
    Haider, Masoom A.
    Cho, Young-Bin
    Jaffray, David
    Lockwood, Gina
    Levin, Wilfred
    Manchul, Lee
    Fyles, Anthony
    Milosevic, Michael
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (05): : 1507 - 1515
  • [5] de Pree I, 2007, RADIOTHER ONCOL, V84, pS168
  • [6] Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer
    Fokdal, L
    Honoré, H
    Hoyer, M
    Meldgaard, P
    Fode, K
    von der Maase, H
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (02): : 436 - 444
  • [7] Interfractional dose variation during intensity-modulated radiation therapy for cervical cancer assessed by weekly CT evaluation
    Han, Youngyih
    Shin, Eun Hyuk
    Huh, Seung Jae
    Lee, Jung Eun
    Park, Won
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (02): : 617 - 623
  • [8] Interfractional variation in position of the uterus during radical radiotherapy for cervical cancer
    Huh, SJ
    Park, W
    Han, Y
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 71 (01) : 73 - 79
  • [9] Online MRI guidance for healthy tissue sparing in patients with cervical cancer: An IMRT planning study
    Kerkhof, Ellen M.
    Raaymakers, Bas W.
    van der Heide, Uulke A.
    van de Bunt, Linda
    Jurgenliemk-Schutz, Ina M.
    Lagendijk, Jan J. W.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 (02) : 241 - 249
  • [10] Intrafraction motion in patients with cervical cancer: The benefit of soft tissue registration using MRI
    Kerkhof, Ellen M.
    van der Put, Richard W.
    Raaymakers, Bas W.
    van der Heide, Uulke A.
    Jurgenliemk-Schulz, Ina M.
    Lagendijk, Jan J. W.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 93 (01) : 115 - 121